IP Library › Granted Patent US 11,672,862
Granted Patent B2
US 11,672,862 · App. 16/707,583 · Granted Jun 13, 2023

Oral products with reduced irritation

Inventors: Anthony Richard Gerardi (Winston-Salem, NC); Dwayne William Beeson (Kernersville, NC); Darrell Eugene Holton, Jr. (Clemmons, NC); Ronald K. Hutchens (East Bend, NC); Christopher Keller (Advance, NC); Thomas H. Poole (Winston-Salem, NC); Andries Don Sebastian (Winston-Salem, NC); Frank Kelley St. Charles (Bowling Green, NC)
Assignee: Nicoventures Trading Limited
A61K47/10A61K9/0056A61K31/455A61K31/52A61K47/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,862
App. No.
16/707,583
Granted
Jun 13, 2023
Kind
B2
Abstract

The disclosure provides products configured for oral use, the products including one or more agents adapted to or configured to reduce irritation that may be associated with release of a component from the products. Xylitol in particular may be useful as an irritation reducing agent. The disclosure further provides methods of reducing irritation associated with the release of one or more components from an oral composition or product.

Claims (27)

1. An oral composition comprising:

an active ingredient that is releasable from the oral composition;

a filler; and

an irritation reducing agent effective to reduce irritation arising from the release of the active ingredient from the oral composition,

wherein the active ingredient comprises nicotine or caffeine,

wherein the active ingredient, the filler component, and the irritation reducing agent are combined as a mixture that is enclosed in a pouch to form a pouched product, the mixture being in a free-flowing particulate form,

wherein the irritation reducing agent is present in an amount effective to reduce the irritation in one or both of a consumer's mouth and throat,

and wherein the filler component is a cellulose material or cellulose derivative selected from the group consisting of methyl cellulose, hydroxypropyl cellulose (HPC), hydroxypropylmethyl cellulose (HPMC), hydroxyethyl cellulose, and carboxymethylcellulose (CMC) and is present in an amount of 20% to 75% by weight based on a total weight of the mixture.

2. The oral composition if claim 1 , wherein the irritation reducing agent comprises a non-sugar sweetener.

3. The oral composition of claim 1 , wherein the irritation reducing agent is selected from the group consisting of xylitol, sorbitol, camphor, clove oil, coco extract, eugenol, vegetable oil, glycerine, and combinations thereof.

4. The oral composition of claim 3 , wherein the irritation reducing agent comprises xylitol.

5. The oral composition of claim 4 , wherein the oral composition further comprises a non-nutritive sweetener in addition to the xylitol.

6. The oral composition of claim 5 , wherein the non-nutritive sweetener comprises one or both of sucralose and aspartame.

7. The oral composition of claim 1 , further comprising one or more flavoring agents.

8. The oral composition of claim 7 , wherein the one or more flavoring agents comprises a compound having a carbon-carbon double bond, a carbon-oxygen double bond, or both.

9. The oral composition of claim 8 , wherein the one or more flavoring agents comprises one or more aldehydes, ketones, esters, terpenes, terpenoids, or a combination thereof.

10. The oral composition of claim 8 , wherein the one or more flavoring agents comprises one or more of ethyl vanillin, cinnamaldehyde, sabinene, limonene, gamma-terpinene, beta-farnesene, and citral.

11. The oral composition of claim 1 , wherein the filler component is in a particulate form.

12. The oral composition of claim 1 , wherein the filler component is microcrystalline cellulose.

13. The oral composition of claim 1 , wherein the pouched product comprises no more than about 10% by weight of a tobacco material, excluding any nicotine component present, based on the total weight of the mixture.

14. The oral composition of claim 1 , wherein the oral composition further comprises one or more salts, one or more binding agents, one or more humectants, one or more gums, a tobacco material, or combinations thereof.

15. The oral composition of claim 1 , wherein the active ingredient is releasable from the oral composition in one or both of the mouth and throat of a consumer.

16. A method for reducing irritation associated with an active ingredient in an oral product, the method comprising:

forming a product to include an irritation reducing agent, an active ingredient that is releasable in one or both of the mouth and throat of a consumer, and a filler component,

wherein the product comprises the oral composition of claim 1 .

17. The method of claim 16 , wherein the irritation reducing agent comprises xylitol.

18. The oral composition of claim 1 , wherein the filler component is present in an amount of 40% to 75% by weight based on the total weight of the mixture.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: GERARDI, ANTHONY RICHARD; BEESON, DWAYNE WILLIAM; HOLTON, DARRELL EUGENE, JR; HUTCHENS, RONALD K.; KELLER, CHRISTOPHER; POOLE, THOMAS H.; SEBASTIAN, ANDRIES DON; ST. CHARLES, FRANK KELLEY
To: NICOVENTURES TRADING LIMITED
Reel/Frame 054297/0472 →
Continuity (1)
Related Publication 20210170028A1 · Jun 10, 2021